Zobrazeno 1 - 10
of 246
pro vyhledávání: '"Jeffrey J, Tosoian"'
Autor:
Udit Singhal, Srinivas Nallandhighal, Jeffrey J. Tosoian, Kevin Hu, Trinh M. Pham, Judith Stangl-Kremser, Chia-Jen Liu, Razeen Karim, Komal R. Plouffe, Todd M. Morgan, Marcin Cieslik, Roberta Lucianò, Shahrokh F. Shariat, Nadia Finocchio, Lucia Dambrosio, Claudio Doglioni, Arul M. Chinnaiyan, Scott A. Tomlins, Alberto Briganti, Ganesh S. Palapattu, Aaron M. Udager, Simpa S. Salami
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-9 (2024)
Abstract Localized prostate cancer is frequently composed of multiple spatially distinct tumors with significant inter- and intra-tumoral molecular heterogeneity. This genomic diversity gives rise to many competing clones that may drive the biologica
Externí odkaz:
https://doaj.org/article/62b4741b814f4ceeb89934d4333d96c5
Autor:
Mingjian Shi, John P. Shelley, Kerry R. Schaffer, Jeffrey J. Tosoian, Minoo Bagheri, John S. Witte, Linda Kachuri, Jonathan D. Mosley
Publikováno v:
EBioMedicine, Vol 97, Iss , Pp 104838- (2023)
Summary: Background: Prostate-specific antigen (PSA) levels are influenced by genetic variation unrelated to prostate cancer risk. Whether a genetic predisposition to a higher PSA level predisposes to a diagnostic work-up for prostate cancer is not k
Externí odkaz:
https://doaj.org/article/569bdb9e3add45e7bb33a4cdf5d17c2b
Autor:
Judith Stangl-Kremser, Sazan Rasul, Jeffrey J. Tosoian, Simpa S. Salami, Alexander Zaslavsky, Aaron Udager, Peter Mazal, Renate Kain, Eva Comperat, Marcus Hacker, Alexander Haug, Markus Mitterhauser, Carmen Pozo-Salido, Christina Steinbach, Melanie R. Hassler, Gero Kramer, Shahrokh F. Shariat, Ganesh S. Palapattu
Publikováno v:
European Urology Open Science, Vol 30, Iss , Pp 63-66 (2021)
Initial reports of a clinical response in patients treated with the radioligand [177Lu]-PSMA-617 for castration-resistant prostate cancer (CRPC) are promising, despite known inter- and intrapatient heterogeneity. In metastatic CRPC, we examined the a
Externí odkaz:
https://doaj.org/article/a2b9edb485a247728f43555379aaa0bd
Autor:
Jeffrey J. Tosoian, Rodney L. Dunn, Yashar S. Niknafs, Anjan Saha, Randy A. Vince, Jr, Jennifer L. St. Sauver, Debra J. Jacobson, Michaela E. McGree, Javed Siddiqui, Jack Groskopf, Steven J. Jacobsen, Scott A. Tomlins, Lakshmi P. Kunju, Todd M. Morgan, Simpa S. Salami, John T. Wei, Arul M. Chinnaiyan, Aruna V. Sarma
Publikováno v:
European Urology Open Science, Vol 29, Iss , Pp 30-35 (2021)
Background: Serum prostate-specific antigen (PSA), used in prostate cancer screening, is nonspecific for cancer and is affected by age and prostate volume. More specific biomarkers could be more accurate for early detection of prostate cancer and red
Externí odkaz:
https://doaj.org/article/26c4855afa5048b6a3973d79f02797bd
Publikováno v:
Urologic Clinics of North America. 50:91-107
We performed a narrative review of studies that produced clinically applicable data by examining the combined use of at least one biomarker test and multiparametric MRI to predict GG ≥2 prostate cancer on biopsy and by reporting the resultant clini
Autor:
Steven B. Goldenthal, Melissa A. Reimers, Udit Singhal, Mark Farha, Rohit Mehra, Morand Piert, Jeffrey J. Tosoian, Parth K. Modi, Nicole Curci, James Peabody, Eduardo Kleer, David C. Smith, Todd M. Morgan
Publikováno v:
Urology. 167:171-178
To aid in the diagnosis and treatment of patients with metastatic tumor seeding, an exceedingly rare phenomenon following minimally invasive urological surgery, additional case reports are needed.We report our experience with patients determined to h
Autor:
David F. Penson, Jeffrey J. Tosoian
Publikováno v:
Journal of Urology.
Publikováno v:
Journal of Urology.
Autor:
Jeffrey J. Tosoian, Yuping Zhang, Lanbo Xiao, Cassie Xie, Nathan L. Samora, Yashar S. Niknafs, Zoey Chopra, Javed Siddiqui, Heng Zheng, Grace Herron, Neil Vaishampayan, Kumaran Arivoli, Bruce J. Trock, Ashley E. Ross, Todd M. Morgan, Ganesh S. Palapattu, Simpa S. Salami, Lakshmi P. Kunju, Yingye Zheng, John T. Wei, Arul M. Chinnaiyan
BackgroundThe benefits of prostate cancer screening with serum prostate-specific antigen (PSA) have been largely offset by the high rate of negative prostate biopsies and overdiagnosis of indolent cancers. These outcomes result from the limited diagn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b638aa811c48f41237fcaec9eefa1ed
https://doi.org/10.1101/2023.04.11.23288418
https://doi.org/10.1101/2023.04.11.23288418
Autor:
Bashir Al Hussein Al Awamlh, Daniel A. Barocas, Alec Zhu, Jeffrey J. Tosoian, Lee Ponsky, Serban Negoita, Jonathan E. Shoag
Publikováno v:
JAMA Internal Medicine.
This cross-sectional study of data from the Surveillance, Epidemiology and End Results database assesses temporal trends in the use of active surveillance and watchful waiting vs definitive treatment in men with low- and favorable intermediate–risk